Literature DB >> 8228252

Mechanism of release of soluble forms of tumor necrosis factor/lymphotoxin receptors by phorbol myristate acetate-stimulated human THP-1 cells in vitro.

C Hwang1, M Gatanaga, G A Granger, T Gatanaga.   

Abstract

The mechanism involved in the release of the soluble forms of 55 and 75 kDa TNF and lymphotoxin (LT) membrane receptors was studied in a continuous human monocytic cell line, THP-1, in vitro. THP-1 cells were found to spontaneously release soluble forms of both 55 and 75 kDa TNF/LT receptors. Release was up-regulated by PMA, and optimal release was achieved at 10(-8) M PMA. Serine protease inhibitors such as PMSF,3,4 dichloroisocoumarin, N alpha-p-tosyl-L-lysine chloromethyl ketone (TLCK), and N-tosyl-L-phenylalanine chloromethyl ketone (TPCK) were found to inhibit the production of both soluble TNF/LT receptors. PMSF (2 mM) also blocked receptors shedding from paraformaldehyde-fixed THP-1 cells coincubated with conditioned media from PMA-stimulated THP-1 cells. Colchicine at 1 and 10 microM stimulated the production of both soluble TNF/LT receptors, but the PMA-induced release of both soluble TNF/LT receptors was inhibited. It appears that the PMA-induced release of soluble TNF/LT receptors involves serine proteases in the extracellular space where the soluble parts of the TNF/LT receptors are cleaved directly off the cell membrane.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8228252

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  mTORC1 activation in B cells confers impairment of marginal zone microarchitecture by exaggerating cathepsin activity.

Authors:  Naresh Kumar Meena; Shakti Prasad Pattanayak; Yael Ben-Nun; Sandrine Benhamron; Saran Kumar; Emmanuelle Merquiol; Nadine Hövelmeyer; Galia Blum; Boaz Tirosh
Journal:  Immunology       Date:  2018-09-16       Impact factor: 7.397

2.  Activated T cells secrete an alternatively spliced form of common γ-chain that inhibits cytokine signaling and exacerbates inflammation.

Authors:  Changwan Hong; Megan A Luckey; Davinna L Ligons; Adam T Waickman; Joo-Young Park; Grace Y Kim; Hilary R Keller; Ruth Etzensperger; Xuguang Tai; Vanja Lazarevic; Lionel Feigenbaum; Marta Catalfamo; Scott T R Walsh; Jung-Hyun Park
Journal:  Immunity       Date:  2014-06-05       Impact factor: 31.745

3.  Soluble tumor necrosis factor alpha receptors (sTNF-Rs) in HIV-1-infected intravenous drug users: change in circulating sTNF-R type II level and survival for AIDS patients.

Authors:  F Ajello; R La Licata; M Lodato; F Vitale; F Bonura; R Valenti; M Bruno; N Romano
Journal:  Eur J Epidemiol       Date:  2000-03       Impact factor: 8.082

4.  Increased serum levels of soluble tumor necrosis factor receptors (sTNF-Rs) in children and adolescents with vertically and horizontally transmitted HIV infection.

Authors:  M Weiss; M Martignoni; T Petropoulou; B Sölder; B H Belohradsky
Journal:  Infection       Date:  1996 Jul-Aug       Impact factor: 3.553

5.  Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNF alpha processing in RA synovial membrane cell cultures.

Authors:  L M Williams; D L Gibbons; A Gearing; R N Maini; M Feldmann; F M Brennan
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

6.  Soluble Axl is generated by ADAM10-dependent cleavage and associates with Gas6 in mouse serum.

Authors:  Vadim Budagian; Elena Bulanova; Zane Orinska; Erwin Duitman; Katja Brandt; Andreas Ludwig; Dieter Hartmann; Greg Lemke; Paul Saftig; Silvia Bulfone-Paus
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

7.  Synthesis and Biological Screening of Pyrano[3,2-c]quinoline Analogues as Anti-inflammatory and Anticancer Agents.

Authors:  Kuldip D Upadhyay; Narsinh M Dodia; Rupesh C Khunt; Ravi S Chaniara; Anamik K Shah
Journal:  ACS Med Chem Lett       Date:  2018-02-23       Impact factor: 4.345

8.  Mannose-capped Lipoarabinomannan from Mycobacterium tuberculosis induces soluble tumor necrosis factor receptor production through tumor necrosis factor alpha-converting enzyme activation.

Authors:  Jillian M Richmond; Elizabeth R Duffy; Jinhee Lee; Kavon Kaboli; Yun Seong Kim; Daniel G Remick; Hardy Kornfeld; William W Cruikshank
Journal:  Infect Immun       Date:  2012-08-27       Impact factor: 3.441

9.  Polymorphisms in the tumor necrosis factor receptor genes affect the expression levels of membrane-bound type I and type II receptors.

Authors:  Sergey V Sennikov; Filipp F Vasilyev; Julia A Lopatnikova; Nadezhda S Shkaruba; Alexander N Silkov
Journal:  Mediators Inflamm       Date:  2014-03-24       Impact factor: 4.711

10.  ALPK1 phosphorylates myosin IIA modulating TNF-α trafficking in gout flares.

Authors:  Chi-Pin Lee; Shang-Lun Chiang; Albert Min-Shan Ko; Yu-Fan Liu; Che Ma; Chi-Yu Lu; Chung-Ming Huang; Jan-Gowth Chang; Tzer-Min Kuo; Chia-Lin Chen; Eing-Mei Tsai; Ying-Chin Ko
Journal:  Sci Rep       Date:  2016-05-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.